A New Risk Variant for Multiple Sclerosis at 11q23.3

CXCR5 genetics genotyping multiple sclerosis single nucleotide polymorphisms targeted DNA sequencing

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
26 Feb 2020
Historique:
received: 16 01 2020
revised: 19 02 2020
accepted: 20 02 2020
entrez: 1 3 2020
pubmed: 1 3 2020
medline: 1 3 2020
Statut: epublish

Résumé

Genome-wide association studies and meta-analysis have contributed to the identification of more than 200

Identifiants

pubmed: 32110891
pii: jcm9030625
doi: 10.3390/jcm9030625
pmc: PMC7141122
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : ISCIII-SGEFI/FEDER
ID : PT13/0001
Organisme : AEI/FEDER
ID : BFU2016-77961-P
Organisme : MINECO
ID : MDM-2014-0370
Organisme : Instituto de Salud Carlos III
ID : PI12/02229, PI15/00587, PI16/01259
Organisme : Red Española de Esclerosis Múltiple
ID : RD16/0015/0004, RD16/0015/0002; RD16/0015/0016
Organisme : Ministerio de Economía, Industria y Competitividad
ID : SAF2016-80595-C2-1-P

Références

Nat Rev Neurol. 2017 Jan;13(1):25-36
pubmed: 27934854
Front Immunol. 2016 Nov 17;7:515
pubmed: 27909439
Nature. 2011 Aug 10;476(7359):214-9
pubmed: 21833088
Immunology. 2005 Sep;116(1):1-12
pubmed: 16108812
Brief Bioinform. 2016 Nov;17(6):980-995
pubmed: 26586731
Brain. 2006 Jan;129(Pt 1):200-11
pubmed: 16280350
J Immunol. 2016 Dec 1;197(11):4257-4265
pubmed: 27798157
J Allergy Clin Immunol. 2010 Nov;126(5):898-907; quiz 908-9
pubmed: 21050940
Int J Cell Biol. 2010;2010:529376
pubmed: 21274427
Immunity. 2011 Jan 28;34(1):108-21
pubmed: 21215658
Nat Neurosci. 2016 Dec;19(12):1599-1609
pubmed: 27820602
Int J Mol Sci. 2012;13(9):11718-52
pubmed: 23109880
J Med Genet. 2013 Jan;50(1):25-33
pubmed: 23160276
Nat Genet. 2009 Jul;41(7):824-8
pubmed: 19525955
Mult Scler Relat Disord. 2014 Mar;3(2):211-219
pubmed: 25568836
Int J Mol Sci. 2018 Oct 04;19(10):
pubmed: 30287763
Nat Genet. 2013 Nov;45(11):1353-60
pubmed: 24076602
Immunol Res. 2019 Oct;67(4-5):416-423
pubmed: 31440888
Clin Exp Immunol. 2013 Dec;174(3):345-55
pubmed: 23968502
Blood. 2014 Oct 23;124(17):2666-74
pubmed: 25224411
J Neuroimmunol. 2004 Mar;148(1-2):11-23
pubmed: 14975582
J Immunol. 2015 Aug 1;195(3):832-40
pubmed: 26071562
Genome Res. 2012 Sep;22(9):1790-7
pubmed: 22955989
J Autoimmun. 2016 Apr;68:62-74
pubmed: 26898941
Nat Immunol. 2013 Feb;14(2):152-61
pubmed: 23242415
Scand J Immunol. 2017 Dec;86(6):452-461
pubmed: 28941291
Am J Hum Genet. 2005 May;76(5):887-93
pubmed: 15789306
Immunol Rev. 2016 May;271(1):246-59
pubmed: 27088919
Brain. 2013 Jun;136(Pt 6):1778-82
pubmed: 23739915
Nat Genet. 2005 Nov;37(11):1217-23
pubmed: 16244653
Mult Scler. 2013 Jun;19(7):871-6
pubmed: 23037546
BMC Immunol. 2015 Feb 12;16:6
pubmed: 25879435
Bioinformatics. 2005 Jan 15;21(2):263-5
pubmed: 15297300
Nature. 2015 Feb 19;518(7539):337-43
pubmed: 25363779
Front Immunol. 2018 Nov 20;9:2704
pubmed: 30524440
Medicine (Baltimore). 2014 Dec;93(28):e281
pubmed: 25526461
JCI Insight. 2017 Nov 16;2(22):
pubmed: 29202449
Hum Mol Genet. 2016 Jan 15;25(2):308-16
pubmed: 26604134
Curr Opin Immunol. 2013 Feb;25(1):103-8
pubmed: 23246037
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Science. 2019 Sep 27;365(6460):
pubmed: 31604244
J Interferon Cytokine Res. 2014 Aug;34(8):577-88
pubmed: 25084174
J Immunol. 2006 Jun 15;176(12):7676-85
pubmed: 16751415
Hum Mol Genet. 2017 Aug 1;26(15):2825-2837
pubmed: 28575206
Nat Med. 2011 Jul 24;17(8):975-82
pubmed: 21785433

Auteurs

Elia Gil-Varea (E)

Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat). Institut de Recerca Vall d'Hebron (VHIR). Hospital Universitari Vall d'Hebron. Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.

Maria Fedetz (M)

Department of Cell Biology and Immunology, Instituto de Parasitología y Biomedicina "López Neyra", Consejo Superior de Investigaciones Científicas (IPBLN-CSIC) 18016 Granada, Spain.

Herena Eixarch (H)

Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat). Institut de Recerca Vall d'Hebron (VHIR). Hospital Universitari Vall d'Hebron. Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.

Nino Spataro (N)

Genetics Laboratory, UDIAT-Centre Diagnòstic. Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí I3PT. Universitat Autònoma de Barcelona, 08208 Sabadell, Spain.

Luisa María Villar (LM)

Departments of Immunology and Neurology, Multiple Sclerosis Unit, Hospital Ramon y Cajal, (IRYCIS), 28034 Madrid, Spain.

Elena Urcelay (E)

Lab. of Genetics of Complex Diseases, Hospital Clinico San Carlos, Instituto de Investigacion Sanitaria San Carlos (IdISSC), 28040 Madrid, Spain.

Albert Saiz (A)

Servicio de Neurología, Hospital Clinic and Institut d'Investigació Biomèdica Pi i Sunyer (IDIBAPS), Universitat de Barcelona, 08036 Barcelona, Spain.

Óscar Fernández (Ó)

Unidad de Gestión Clínica de Neurociencias. Instituto de Investigación Biomédica de Málaga (IBIMA), Hospital Regional Universitario de Málaga. Universidad de Málaga, 29010 Málaga, Spain.

Laura Leyva (L)

Unidad de Gestión Clínica de Neurociencias. Instituto de Investigación Biomédica de Málaga (IBIMA), Hospital Regional Universitario de Málaga. Universidad de Málaga, 29010 Málaga, Spain.

Lluís Ramió-Torrentà (L)

Girona Neuroimmunology and Multiple Sclerosis Unit, Neurology Department, Dr. Josep Trueta University Hospital. Neurodegeneration and Neuroinflammation Group, Girona Biomedical Research Institute (IdIBGi). Department of Medical Sciences, Faculty of Medicine, University of Girona, 17190 Girona, Spain.

Koen Vandenbroeck (K)

Inflammation & Biomarkers Group, Biocruces Bizkaia Health Research Institute, 48903 Barakaldo, Spain.
IKERBASQUE, Basque Foundation for Science, 48013 Bilbao, Spain.

David Otaegui (D)

Neurosciences Area, Biodonostia Health Research Institute, 20014 San Sebastián, Spain.

Tamara Castillo-Triviño (T)

Servicio de Neurología, Hospital Universitario Donostia, 20014 San Sebastián, Spain.

Guillermo Izquierdo (G)

Departamento de Neurología, Hospital Universitario Virgen Macarena, 41009 Sevilla, Spain.

Sunny Malhotra (S)

Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat). Institut de Recerca Vall d'Hebron (VHIR). Hospital Universitari Vall d'Hebron. Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.

Elena Bosch (E)

Institute of Evolutionary Biology (CSIC-UPF), Department of Experimental and Health Sciences, Universitat Pompeu Fabra, 08003 Barcelona, Spain.
Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Reus, Spain.

Arcadi Navarro (A)

Institute of Evolutionary Biology (CSIC-UPF), Department of Experimental and Health Sciences, Universitat Pompeu Fabra, 08003 Barcelona, Spain.
Centre de Regulació Genòmica (CRG), 08003 Barcelona, Spain.
Institució Catalana de Recerca i Estudis Avançats (ICREA), 08010 Barcelona, Spain.

Antonio Alcina (A)

Department of Cell Biology and Immunology, Instituto de Parasitología y Biomedicina "López Neyra", Consejo Superior de Investigaciones Científicas (IPBLN-CSIC) 18016 Granada, Spain.

Xavier Montalban (X)

Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat). Institut de Recerca Vall d'Hebron (VHIR). Hospital Universitari Vall d'Hebron. Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.
Center for Multiple Sclerosis, St. Michael's Hospital, University of Toronto, Toronto, ON M5S 1A1, Canada.

Fuencisla Matesanz (F)

Department of Cell Biology and Immunology, Instituto de Parasitología y Biomedicina "López Neyra", Consejo Superior de Investigaciones Científicas (IPBLN-CSIC) 18016 Granada, Spain.

Manuel Comabella (M)

Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat). Institut de Recerca Vall d'Hebron (VHIR). Hospital Universitari Vall d'Hebron. Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.

Classifications MeSH